Tweet
Pneumococcal Vaccination and Risk of Acute Myocardial Infarction and Stroke in Men (JAMA, May 5, 2010, abstract, edited)
[Source: JAMA, original abstract (LINK). Edited.]
Pneumococcal Vaccination and Risk of Acute Myocardial Infarction and Stroke in Men
**** Fu Tseng, PhD; Jeffrey M. Slezak, MS; Virginia P. Quinn, PhD; Lina S. Sy, MPH; Stephen K. Van Den Eeden, PhD; Steven J. Jacobsen, MD, PhD
JAMA. 2010;303(17):1699-1706.
Context
Multiple studies have shown that preventing influenza by vaccination reduces the risk of vascular events. However, the effect of pneumococcal polysaccharide vaccine on vascular events remains controversial.
Objective
To examine the association between pneumococcal vaccination and risk of acute myocardial infarction (MI) and stroke among men.
Design, Setting, and Participants
A prospective cohort study of Kaiser Permanente Northern and Southern California health plans with 84 170 participants aged 45 to 69 years from the California Men's Health Study who were recruited between January 2002 and December 2003, and followed up until December 31, 2007. The cohort was similar to the population of health plan members and men who responded to a general health survey in California on important demographic and clinical characteristics. Demographic and detailed lifestyle characteristics were collected from surveys. Vaccination records were obtained from the Kaiser Immunization Tracking System.
Main Outcome Measure
Incidence of acute MI and stroke during the follow-up period in men who had no history of such conditions.
Results
During follow-up, there were 1211 first MIs in 112 837 vaccinated person-years (10.73 per 1000 person-years) compared with 1494 first MI events in 246 170 unvaccinated person-years (6.07 per 1000 person-years). For stroke, there were 651 events in 122 821 vaccinated person-years (5.30 per 1000 person-years) compared with 483 events in 254 541 unvaccinated person-years (1.90 per 1000 person-years). With propensity score adjustment, we found no evidence for an association between pneumococcal vaccination and reduced risk of acute MI (adjusted hazard ratio [HR], 1.09; 95% confidence interval [CI], 0.98-1.21) or stroke (adjusted HR, 1.14; 95% CI, 1.00-1.31). An inverse association was also not found in men of different age and risk groups. The results appeared to be consistent, because using more specific International Classification of Diseases, Ninth Revision codes for the outcome definition did not change the estimations.
Conclusion
Among a cohort of men aged 45 years or older, receipt of pneumococcal vaccine was not associated with subsequent reduced risk of acute MI and stroke.
Author Affiliations:
Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (Drs Tseng, Quinn, and Jacobsen and Mr Slezak and Ms Sy); and Division of Research, Kaiser Permanente Northern California, Oakland (Dr Van Den Eeden).
-
-----
[Source: JAMA, original abstract (LINK). Edited.]
Pneumococcal Vaccination and Risk of Acute Myocardial Infarction and Stroke in Men
**** Fu Tseng, PhD; Jeffrey M. Slezak, MS; Virginia P. Quinn, PhD; Lina S. Sy, MPH; Stephen K. Van Den Eeden, PhD; Steven J. Jacobsen, MD, PhD
JAMA. 2010;303(17):1699-1706.
Context
Multiple studies have shown that preventing influenza by vaccination reduces the risk of vascular events. However, the effect of pneumococcal polysaccharide vaccine on vascular events remains controversial.
Objective
To examine the association between pneumococcal vaccination and risk of acute myocardial infarction (MI) and stroke among men.
Design, Setting, and Participants
A prospective cohort study of Kaiser Permanente Northern and Southern California health plans with 84 170 participants aged 45 to 69 years from the California Men's Health Study who were recruited between January 2002 and December 2003, and followed up until December 31, 2007. The cohort was similar to the population of health plan members and men who responded to a general health survey in California on important demographic and clinical characteristics. Demographic and detailed lifestyle characteristics were collected from surveys. Vaccination records were obtained from the Kaiser Immunization Tracking System.
Main Outcome Measure
Incidence of acute MI and stroke during the follow-up period in men who had no history of such conditions.
Results
During follow-up, there were 1211 first MIs in 112 837 vaccinated person-years (10.73 per 1000 person-years) compared with 1494 first MI events in 246 170 unvaccinated person-years (6.07 per 1000 person-years). For stroke, there were 651 events in 122 821 vaccinated person-years (5.30 per 1000 person-years) compared with 483 events in 254 541 unvaccinated person-years (1.90 per 1000 person-years). With propensity score adjustment, we found no evidence for an association between pneumococcal vaccination and reduced risk of acute MI (adjusted hazard ratio [HR], 1.09; 95% confidence interval [CI], 0.98-1.21) or stroke (adjusted HR, 1.14; 95% CI, 1.00-1.31). An inverse association was also not found in men of different age and risk groups. The results appeared to be consistent, because using more specific International Classification of Diseases, Ninth Revision codes for the outcome definition did not change the estimations.
Conclusion
Among a cohort of men aged 45 years or older, receipt of pneumococcal vaccine was not associated with subsequent reduced risk of acute MI and stroke.
Author Affiliations:
Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (Drs Tseng, Quinn, and Jacobsen and Mr Slezak and Ms Sy); and Division of Research, Kaiser Permanente Northern California, Oakland (Dr Van Den Eeden).
-
-----
Comment